Geron Corp. (GERN)
1.225
0.00 (0.00%)
USD |
NASDAQ |
Oct 12, 12:02
Geron Net Income (TTM) : -69.89M for June 30, 2026
Net Income (TTM) Chart
Historical Net Income (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | -69.89M |
| March 31, 2026 | -69.59M |
| December 31, 2025 | -85.78M |
| September 30, 2025 | -79.99M |
| June 30, 2025 | -88.01M |
| March 31, 2025 | -139.02M |
| December 31, 2024 | -174.57M |
| September 30, 2024 | -201.19M |
| June 30, 2024 | -219.55M |
| March 31, 2024 | -201.40M |
| December 31, 2023 | -184.13M |
| September 30, 2023 | -174.79M |
| June 30, 2023 | -171.04M |
| March 31, 2023 | -149.92M |
| December 31, 2022 | -141.90M |
| September 30, 2022 | -131.28M |
| June 30, 2022 | -116.93M |
| March 31, 2022 | -118.39M |
| December 31, 2021 | -116.11M |
| September 30, 2021 | -107.88M |
| June 30, 2021 | -100.84M |
| March 31, 2021 | -87.09M |
| December 31, 2020 | -75.62M |
| September 30, 2020 | -80.90M |
| June 30, 2020 | -76.43M |
| Date | Value |
|---|---|
| March 31, 2020 | -74.84M |
| December 31, 2019 | -68.55M |
| September 30, 2019 | -46.78M |
| June 30, 2019 | -37.20M |
| March 31, 2019 | -29.89M |
| December 31, 2018 | -27.02M |
| September 30, 2018 | -27.15M |
| June 30, 2018 | -28.45M |
| March 31, 2018 | -27.92M |
| December 31, 2017 | -27.92M |
| September 30, 2017 | -28.97M |
| June 30, 2017 | -25.65M |
| March 31, 2017 | -27.88M |
| December 31, 2016 | -29.54M |
| September 30, 2016 | -29.52M |
| June 30, 2016 | 1.238M |
| March 31, 2016 | 0.519M |
| December 31, 2015 | 0.046M |
| September 30, 2015 | -0.433M |
| June 30, 2015 | -37.17M |
| March 31, 2015 | -36.54M |
| December 31, 2014 | -35.67M |
| September 30, 2014 | -36.00M |
| June 30, 2014 | -34.71M |
| March 31, 2014 | -34.92M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (TTM) Benchmarks
| Precigen, Inc. | -157.70M |
| Editas Medicine, Inc. | -73.95M |
| Agenus, Inc. | 91.94M |
| Amgen, Inc. | 8.743B |
| Anika Therapeutics, Inc. | -3.121M |